HOME › DRUGS › NEMOLIZUMAB
ACTIVE SUBSTANCE / INN

NEMOLIZUMAB

Brand name(s): Nemluvio
EMA LISTED
AUTHORISED
Dermatitis, Atopic;Prurigo
ACTIVE SUBSTANCE
Nemolizumab
REGULATORS
EMA
SPONSORS / MAH
Galderma International
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NemluvioGalderma InternationalAuthorised12/02/2025Dermatitis, Atopic;Prurigo

FULL INTELLIGENCE ON NEMOLIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →